Vitamin D3 "Mirrola®"

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.001305.03.18
Date of registration and renewal:28.03.2018
Dosage form: & nbspCapsules weighing 260 mg, liquid in bottles with a dispenser-dropper from 10 to 30 ml.
Classification "Composition" & nbsp BADs - fats, fatty substances and their derivatives BAD - products of plant, animal or mineral origin Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp BAD-source of monovitamins and vitamin-like substances
Composition: & nbspCapsules: vegetable oil refined (olive, or corn, or sunflower, or other food) capsule shell: (gelatin food, glycerin, citric acid, water), cholecalciferol.
Liquid: vegetable oil refined (olive, or corn, or sunflower, or other food), cholecalciferol.
Scope: & nbspFor realization to the population as a biologically active additive to food - an additional source of vitamin D3.
Suggested Usage: & nbspAdults and children over 3 years of age per 1 capsule or 5 drops (200 mg) of liquid form once a day during meals, squeezed with liquid. Duration of admission is 1 month.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:24 months for capsules, 12 months for liquid form.
Storage conditions:Store in original original packaging, out of reach of children, at a temperature not exceeding 25 ° C.
Research protocols:In exchange for the certificate of state registration No.RU.77.99.88.003.E.000249.01.17 of 23.01.2017; expert opinion of FGBUN "FIC of nutrition and biotechnology" No. 529 / E-10 / b-17 of 12/01/2017.
Recipient:Mirrola, Open CompanyMirrola, Open Company Russia
Information update date: & nbsp22.06.2018
Instructions
Up